Regulon

Regulon: R-915

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
12-2.8141318Pr-62Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
55679 ENSG00000072163 LIMS2 Q7Z4I7
10683 ENSG00000090932 DLL3 Q9NYJ7
4324 ENSG00000102996 MMP15 P51511
7434 ENSG00000106018 VIPR2 P41587
25806 ENSG00000116035 VAX2 Q9UIW0
10912 ENSG00000130222 GADD45G O95257
63827 ENSG00000132692 BCAN Q96GW7
429 ENSG00000139352 ASCL1 P50553
55765 ENSG00000163362 C1orf106 C9JAT8
10023 ENSG00000165879 FRAT1 Q92837
8971 ENSG00000184897 H1FX Q92522
1028 ENSG00000273707 CDKN1C P49918

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
ROVALPITUZUMAB TESIRINEDLL3AntibodyBINDING AGENTDelta-like protein 3 binding agent30

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-915

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-07162ATRXup-regulatesZNF281activatesR-915248Drugs (1)

Regulator Drugs (0)

Regulon Drugs (1)

ROVALPITUZUMAB TESIRINE

CMF-11811DNAH17up-regulatesZNF281activatesR-915243Drugs (1)

Regulator Drugs (0)

Regulon Drugs (1)

ROVALPITUZUMAB TESIRINE

CMF-13657FMN1up-regulatesZNF281activatesR-9152414Drugs (1)

Regulator Drugs (0)

Regulon Drugs (1)

ROVALPITUZUMAB TESIRINE

CMF-22973IDH1up-regulatesZNF281activatesR-9152415Drugs (1)

Regulator Drugs (0)

Regulon Drugs (1)

ROVALPITUZUMAB TESIRINE

CMF-24104TP53up-regulatesZNF281activatesR-9152411Drugs (1)

Regulator Drugs (0)

Regulon Drugs (1)

ROVALPITUZUMAB TESIRINE

CMF-25837CD163up-regulatesZNF281activatesR-915241Drugs (1)

Regulator Drugs (0)

Regulon Drugs (1)

ROVALPITUZUMAB TESIRINE

CMF-26516EGFRdown-regulatesZNF281activatesR-915248Drugs (1)

Regulator Drugs (0)

Regulon Drugs (1)

ROVALPITUZUMAB TESIRINE

CMF-29255AQP10up-regulatesZNF281activatesR-915244Drugs (1)

Regulator Drugs (0)

Regulon Drugs (1)

ROVALPITUZUMAB TESIRINE